Submitted by Anonymous (not verified) on 19 May 2025 - 15:27
Human medicines European public assessment report (EPAR): Briviact (in Italy: Nubriveo), brivaracetam, Date of authorisation: 13/01/2016, Revision: 25, Status: Authorised
Source: